There were 15 deaths from influenza and pneumonia reported in Oklahoma in the week ending Nov. 5, making up 1.8% of total deaths by all causes in Oklahoma.
There were 196 deaths with cancer listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, a 36.1% increase over the previous week.
There were less than 10 deaths from nephritis, nephrotic syndrome and nephrosis reported in Oklahoma in the week ending Nov. 5, making up less than 1.2% of total deaths by all causes in Oklahoma.
There were 10 deaths with COVID-19 listed as the underlying cause reported in Oklahoma in the week ending Oct. 22, making up 2.5% of total deaths by all causes in Oklahoma.
There were 30 deaths with cerebrovascular disease listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, no changes from the previous week.
There were 47 deaths with chronic lower respiratory disease listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, a 6% decrease from the previous week.
There were 15 deaths with COVID-19 listed as a contributing cause reported in Oklahoma in the week ending Oct. 22, making up 3.7% of total deaths by all causes in Oklahoma.
There were 23 deaths with diabetes mellitus listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, a 21.1% increase over the previous week.
There were 110 deaths from diseases of the heart reported in Oklahoma in the week ending Oct. 22, making up 27.2% of total deaths by all causes in Oklahoma.
There were 28 deaths with Alzheimer's disease listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, a 6.7% decrease from the previous week.
There were less than 10 deaths with nephritis, nephrotic syndrome and nephrosis listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, a decrease from the previous week.
There were 15 deaths with influenza and pneumonia listed as the underlying cause reported in Oklahoma during the week ending Nov. 5, 2022, an increase over the previous week.